Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Treating ER+ breast cancer patients with endocrine therapy resistance. That video is uploaded by VJOncology at 2021-04-21T02:25:41-07:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [dnLr4xzxPuc]
| Name | Treating ER+ breast cancer patients with endocrine therapy resistance |
| Video Uploader | Video From VJOncology |
| Upload Date | This Video Uploaded At 21-04-2021 09:25:41 |
| Video Discription | Nikhil Wagle, MD, Dana-Farber Cancer Institute, Boston, MA, outlines mechanisms of resistance to endocrine therapies in estrogen receptor-positive (ER+) metastatic breast cancer, such as alterations in the estrogen receptor, alternative pathway activation and subtype alteration. Dr Wagle describes how different approaches are required to treat patients with different mechanisms of resistance. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021. dnLr4xzxPuc |
| Category | Education |
| Tags | Speaker: Nikhil Wagle | Institution: Dana-Farber Cancer Institute | Event: VJVirtual | Event: AACR 2021 | Format: Interview | Subject: Breast Cancer | Field: Treatment | Field: Disease Biology | resistance | ER+ | CDK4/6 inhibitors | endocrine therapies | MAP kinase |
